These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28927788)

  • 21. RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities.
    Rai R; Chauhan SK; Singh VV; Rai M; Rai G
    PLoS One; 2016; 11(11):e0166312. PubMed ID: 27835693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathogenic autoantibodies in systemic lupus erythematosus are derived from both self-reactive and non-self-reactive B cells.
    Zhang J; Jacobi AM; Wang T; Diamond B
    Mol Med; 2008; 14(11-12):675-81. PubMed ID: 18677426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and serological associations of autoantibodies in patients with systemic lupus erythematosus.
    Correa-Rodríguez M; Pocovi-Gerardino G; Callejas-Rubio JL; Ríos-Fernández R; Martín-Amada M; Cruz-Caparrós MG; Rueda-Medina B; Ortego-Centeno N
    J Investig Med; 2021 Dec; 69(8):1417-1425. PubMed ID: 34183445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients.
    Syahidatulamali CS; Wan Syamimee WG; Azwany YN; Wong KK; Che Maraina CH
    J Postgrad Med; 2017; 63(4):257-261. PubMed ID: 28862243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL/Faslpr mice through ameliorating inflammation via the PKCδ-NLRC4 axis.
    Yang F; Yang Y; Zeng W
    Biochem Cell Biol; 2021 Jun; 99(3):313-321. PubMed ID: 33064961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2014 May; 34(4):491-503. PubMed ID: 24659206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased levels of anti-dsDNA antibodies in immune complexes before treatment with belimumab associate with clinical response in patients with systemic lupus erythematosus.
    Sohrabian A; Parodis I; Carlströmer-Berthén N; Frodlund M; Jönsen A; Zickert A; Sjöwall C; Bengtsson AA; Gunnarsson I; Rönnelid J
    Arthritis Res Ther; 2019 Nov; 21(1):259. PubMed ID: 31783909
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of polyamines on the binding of anti-DNA antibodies from patients with SLE and normal human subjects.
    Wang X; Stearns NA; Li X; Pisetsky DS
    Clin Immunol; 2014 Jul; 153(1):94-103. PubMed ID: 24732074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The homogeneous multiplexed system--a new method for autoantibody profile in systemic lupus erythematosus.
    Zandman-Goddard G; Gilburd B; Shovman O; Blank M; Berdichevski S; Langevitz P; Shoenfeld Y
    Clin Dev Immunol; 2005 Jun; 12(2):107-11. PubMed ID: 16050141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER; McDonnell JM; Sutton BJ; Staines NA
    Arthritis Rheum; 2000 Feb; 43(2):429-39. PubMed ID: 10693885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perinuclear anti-neutrophil cytoplasmic antibody in systemic lupus erythematosus indicates more severe condition.
    Pan Y; He L
    Clin Biochem; 2021 Mar; 89():38-43. PubMed ID: 33307059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A peptide DNA surrogate that binds and inhibits anti-dsDNA antibodies.
    Zhang W; Reichlin M
    Clin Immunol; 2005 Dec; 117(3):214-20. PubMed ID: 16290070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-dsDNA in the pathogenesis of systemic lupus erythematosus.
    Bai Y; Tong Y; Liu Y; Hu H
    Clin Exp Immunol; 2018 Jan; 191(1):1-10. PubMed ID: 28836661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.
    Dai Y; Li E; Chen D; Niu X; Wang Z; Lu L; Zheng B
    Front Immunol; 2022; 13():913714. PubMed ID: 36189276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody against chromatin assembly factor-1 is a novel autoantibody specifically recognized in systemic lupus erythematosus.
    Doe K; Nozawa K; Hiruma K; Yamada Y; Matsuki Y; Nakano S; Ogasawara M; Nakano H; Ikeda T; Ikegami T; Fujishiro M; Kawasaki M; Ikeda K; Amano H; Morimoto S; Ogawa H; Takamori K; Sekigawa I; Takasaki Y
    Lupus; 2014 Sep; 23(10):1031-41. PubMed ID: 24836587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation.
    Chauhan SK; Singh VV; Rai R; Rai M; Rai G
    J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus antibodies mark systemic lupus erythematosus and scleroderma patients negative for anti-DNA.
    Fattal I; Shental N; Molad Y; Gabrielli A; Pokroy-Shapira E; Oren S; Livneh A; Langevitz P; Pauzner R; Sarig O; Gafter U; Domany E; Cohen IR
    Immunology; 2014 Feb; 141(2):276-85. PubMed ID: 24164500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-double Stranded DNA Antibodies: Origin, Pathogenicity, and Targeted Therapies.
    Wang X; Xia Y
    Front Immunol; 2019; 10():1667. PubMed ID: 31379858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.